Sales news

Enrollment and Randomization of 12,463 Participants Complete in BiondVax's Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine trial

External page is loading, the page should display in a few seconds..

    Follow @newslocke_sales on Twitter!